AMIORG vs NOVARTIND: Stock Comparison

AMIORG vs Novartis India LimitedUpdated 30 May 25, 4:01 PM ISTNSE & company filings

AMIORG is the larger company by market capitalisation. AMIORG shows a higher ROE, while Novartis India Limited shows a lower P/E, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AMIORG leads 3; NOVARTIND leads 10 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AMIORGNOVARTIND

Valuation lens

What price are you paying?

Market CapContext only
₹27,065 Cr
₹3,664 Cr
P/E RatioNOVARTIND has the lower reading
43.06x
37.65x
P/B RatioNOVARTIND has the lower reading
6.82x
4.5x
EPSNOVARTIND has the higher reading
₹0
₹37.76
Book ValueContext only
₹0
₹331.34
Dividend YieldNOVARTIND has the higher reading
0.04%
1.7%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
AMIORG is the larger company
₹27,065 Cr vs ₹3,664 Cr
P/E Ratio
NOVARTIND has a lower P/E
37.65x vs 43.06x
P/B Ratio
NOVARTIND has a lower P/B
4.5x vs 6.82x
EPS
NOVARTIND has higher earnings per share
₹37.76 vs ₹0
Dividend Yield
NOVARTIND has a higher dividend yield
1.7% vs 0.04%
Revenue Growth (TTM YoY)
NOVARTIND has faster revenue growth
8% vs 0%
EPS Growth (TTM YoY)
AMIORG has faster EPS growth
0% vs -13.8%
Qtr Sales Growth
NOVARTIND has stronger quarterly sales growth
7.95% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAMIORGNOVARTIND
SectorHealthcare
IndustryPharmaceuticals

Price

MetricAMIORGNOVARTIND
Live Price₹1,176.3₹1,486.3
Day Change-0.31%-1.06%
Volume2.43 L6,845
52-Week High₹1,194.2₹1,780
52-Week Low₹1,170.1₹950
Distance from 52W High-1.5%-16.5%

Valuation

MetricAMIORGNOVARTIND
Market Cap₹27,065 Cr₹3,664 Cr
P/E Ratio43.06x37.65x
P/B Ratio6.82x4.5x
EPS₹0₹37.76
Book Value₹0₹331.34
Dividend Yield0.04%1.7%

Growth

MetricAMIORGNOVARTIND
Revenue Growth (TTM YoY)0%8%
EPS Growth (TTM YoY)0%-13.8%
Qtr Sales Growth0%7.95%
Qtr Profit Growth0%-13.8%

Profitability & Leverage

MetricAMIORGNOVARTIND
ROE12.15%11.6%
ROCE0%16.2%
Net Margin15.93%26.3%
Operating Margin22.09%26.6%
Debt to Equity0.01x0x

Shareholding

As of Sep 2025 • change vs previous quarter
MetricAMIORGNOVARTIND
Promoter Holding0.33% 32.33 pp0%
FII Holding0.17% 16.77 pp0.16% 0.01 pp
DII Holding0.23% 22.15 pp1.36% 0.83 pp
Public Holding0.28% 27.73 pp27.8% 0.81 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AMIORG and Novartis India Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.